New Skin Saver
Despite all the exhortations to stay out of the sun, a million Americans will develop skin cancer this year. The only good news for die-hard sun worshippers is that treatments are improving. The FDA just gave 3M Pharmaceuticals the go-ahead to market Aldara as a therapy for a common type of basal-cell carcinoma (BCC) — the first new topical approved for BCC in 25 years. In trials, cancerous lesions cleared up after three months for more than 80% of patients.
A new medication helps, but it's no reason to throw common sun-sense to the wind. Aldara does not treat superficial BCC tumors larger in diameter than .8 in.; in those cases, surgery or other treatment will still be required.
Most Popular »
- Sex, Please, We're British: London's Erotica Expo
- The Growing Backlash Against Overparenting
- Toilets
- Woman Loses Benefits over Facebook Photo
- Talking with the Taliban: Easier Said Than Done
- East Antarctica, Long Stable, Is Now Losing Ice
- Is This the End of the Line for Saab?
- Why Exercise Won't Make You Thin
- The Fall of Greg Craig, Obama's Top Lawyer
- Super-Crocodiles May Have Dined on Dinosaurs
- The Growing Backlash Against Overparenting
- Sex, Please, We're British: London's Erotica Expo
- Will Private Equity Be the Next Meltdown?
- Why Exercise Won't Make You Thin
- Singh in Washington: Making the Case for India
- The Dark Side of Darwin's Legacy
- Toilets
- Spanish Outraged by Teen Masturbation Workshops
- Reburying Albert Camus: A Political Ploy by Sarkozy?
- The Political Fallout of Egypt's Soccer War
Quotes of the Day »
MANOJ, a police officer stationed in Mumbai, on why he and other police don't criticize their leaders for failing to meet promises to improve dire working conditions after last fall's deadly attacks on the Taj hotel
Quotes of the Day »
MANOJ, a police officer stationed in Mumbai, on why he and other police don't criticize their leaders for failing to meet promises to improve dire working conditions after last fall's deadly attacks on the Taj hotel
RSS